Characterization of the Inducer of Short Transcripts, a Human Immunodeficiency Virus type 1 Transcriptional Element That Activates the Synthesis of Short RNAs

References

• Bengal, E., and Y. Aloni. 1991. Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation responsive region of human immunodeficiency virus type 1 in vitro. J. Virol. 65:4910–4918.
   PubMedGoogle Scholar
• Bentley, D. L., and Μ. Grondine. 1988. Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53:245–256.
   PubMed Web of Science ®Google Scholar
• Berkhout, B., R. H. Silverman, and K. T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273–282.
   PubMed Web of Science ®Google Scholar
• Cordingley, Μ. G., R. L. LaFemina, P. L. Callahan, J. H. Condra, V. V. Sardana, D. J. Graham, T. Μ. Nguyen, K. LeGrow, L. Gotlib, A. J. Schlabach, and R. J. Colonno. 1990. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 87:8985–8989.
   PubMed Web of Science ®Google Scholar
• Cullen, B. R. 1986. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973–982.
   PubMed Web of Science ®Google Scholar
• Cullen, B. R. 1990. The HIV-1 Tat protein: an RNA sequencespecific processivity factor? Cell 63:655–657.
   PubMed Web of Science ®Google Scholar
• Cullen, B. R. 1991. Regulation of HIV-1 expression. FASEB J. 5:2361–2368.
   PubMed Web of Science ®Google Scholar
• Dahlberg, J. E., and E. Lund. 1988. The genes and transcription of the major small nuclear RNAs, p. 38–70. In Μ. L. Birnstiel (ed.), Structure and function of major and minor small nuclear ribonucleoprotein particles. Springer-Verlag, Berlin.
   Google Scholar
• Delling, U., L. S. Reid, R. W. Barnett, Μ. Y.-X. Ma, S. Climie, Μ. Sumner-Smith, and N. Sonenberg. 1992. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. J. Virol. 66:3018–3025.
   PubMedGoogle Scholar
• Dingwall, C., I. Ernberg, Μ. J. Gait, S. Μ. Green, S. Heaphy, J. Karn, A. D. Lowe, and Μ. Singh. 1989. Human immunodeficiency virus 1 tat protein binds trans-activation responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86:6925–6929.
   PubMed Web of Science ®Google Scholar
• Dingwall, C., I. Ernberg, Μ. J. Gait, S. Μ. Green, S. Heaphy, J. Karn, A. D. Lowe, Μ. Singh, and Μ. A. Skinner. 1990. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:4145–4153.
   PubMed Web of Science ®Google Scholar
• Feinberg, Μ. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045–4049.
   PubMed Web of Science ®Google Scholar
• Feng, S., and E. C. Holland. 1988. HIV-1 tat trans-activation requires the loop sequence within tar. Nature (London) 334:165–167.
   PubMed Web of Science ®Google Scholar
• Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189–1193.
   PubMed Web of Science ®Google Scholar
• Garcia, J. A., D. Harrich, E. Soultanakis, F. Wu, R. Mitsuyasu, and R. B. Gaynor. 1989. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:765–778.
   PubMed Web of Science ®Google Scholar
• Gatignol, A., W. A. Buckler, B. Berkhourt, and K. T. Jeang. 1991. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251:1597–1600.
   PubMed Web of Science ®Google Scholar
• Gatignol, A., A. Kumar, A. Rabson, and K.-T. Jeang. 1989. Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-response TAR element RNA. Proc. Natl. Acad. Sci. USA 86:7828–7832.
   PubMedGoogle Scholar
• Gaynor, R., E. Soultanakis, Μ. Kuwabara, J. Garcia, and D. S. Sigman. 1989. Specific binding of a HeLa nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. Proc. Natl. Acad. Sci. USA 86:4858–4862.
   PubMed Web of Science ®Google Scholar
• Graham, G. J., and J. J. Maio. 1990. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc. Natl. Acad. Sci. USA 87:5817–5821.
   PubMedGoogle Scholar
• Greenberg, Μ. E., and T. P. Bender. 1987. Identification of newly transcribed RNA, p. 4.10.3. In F. Μ. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Green Publishing Associates.
   Google Scholar
• Hauber, J., and B. R. Cullen. 1988. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J. Virol. 62:673–679.
   PubMed Web of Science ®Google Scholar
• Heaphy, S., C. Dingwall, I. Ernberg, Μ. J. Gait, S. Μ. Green, J. Karn, A. D. Lowe, Μ. Singh, and Μ. A. Skinner. 1990. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-and-loop structure located within the Rev response element. Cell 60:685–693.
   PubMedGoogle Scholar
• Hernandez, N. Transcription of vertebrate snRNA genes and related genes. Cold Spring Harbor Monogr. Ser., in press.
   Google Scholar
• Hernandez, N., and R. Lucito. 1988. Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA 3' end formation. EMBO J. 7:3125–3134.
   PubMedGoogle Scholar
• Hernandez, N., and A. Μ. Weiner. 1986. Formation of the 3' end of U1 snRNA requires compatible snRNA promoter elements. Cell 47:249–258.
   PubMed Web of Science ®Google Scholar
• Izban, Μ. G., and D. S. Luse. 1992. The RNA polymerase II ternary complex cleaves the nascent transcript in a 3' to 5' direction in the presence of elongation factor SII. Genes Dev. 6:1342–1356.
   PubMed Web of Science ®Google Scholar
• Jakobovits, A., D. H. Smith, E. B. Jakobovits, and D. J. Capon. 1988. A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol. Cell. Biol. 8:2555–2561.
   PubMed Web of Science ®Google Scholar
• Jones, K. A., P. A. Luciw, and N. Duchange. 1988. Structural arrangements of transcription control domains within the 5'-Untranslated leader regions of the HIV-I and HIV-2 promoters. Genes Dev. 2:1101–1114.
   PubMed Web of Science ®Google Scholar
• Kao, S. Y., A. F. Calman, P. A. Luciw, and B. Μ. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (London) 330:489–493.
   PubMed Web of Science ®Google Scholar
• Kato, H., Μ. Horikoshi, and R. G. Roeder. 1991. Repression of HIV-1 transcription by a cellular protein. Science 251:1476–1479.
   PubMed Web of Science ®Google Scholar
• Kato, H., H. Sumimoto, P. Pognonec, C.-H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655–666.
   PubMed Web of Science ®Google Scholar
• Kerppola, T. K., and C. Μ. Kane. 1988. Intrinsic sites of transcription termination and pausing in the c-myc gene. Mol. Cell. Biol. 8:4389–4394.
   PubMedGoogle Scholar
• Kessler, M., and Μ. B. Mathews. 1991. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication. Proc. Natl. Acad. Sci. USA 88:10018–10022.
   PubMedGoogle Scholar
• Kessler, M., and Μ. B. Mathews. 1992. Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts. J. Virol. 66:4488–4496.
   PubMedGoogle Scholar
• Kuhn, A., and I. Grummt. 1989. 3'-end formation of mouse pre-RNA involves both transcription termination and a specific processing reaction. Genes Dev. 3:224–231.
   PubMedGoogle Scholar
• Laspia, Μ. F., A. P. Rice, and Μ. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283–292.
   PubMed Web of Science ®Google Scholar
• Laspia, Μ. F., A. P. Rice, and Μ. B. Mathews. 1990. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4:2397–2408.
   PubMedGoogle Scholar
• Lisziewicz, J., J. Rappaport, and R. Dhar. 1991. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biol. 3:82–89.
   PubMedGoogle Scholar
• Madore, S. T., E. D. Wieben, and T. Pederson. 1984. Intracellular site of U1 small nuclear RNA processing and ribonucleoprotein assembly. J. Cell Biol. 98:188–192.
   PubMed Web of Science ®Google Scholar
• Malim, Μ. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev transactivator to its RNA target sequence. Cell 60:675–683.
   PubMed Web of Science ®Google Scholar
• Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63:791–802.
   PubMed Web of Science ®Google Scholar
• Marciniak, R. A∙, B. Μ. Garcia, and P. A. Sharp. 1990. Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation response (TAR) element of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:3624–3628.
   PubMed Web of Science ®Google Scholar
• Marciniak, R. A., and P. A. Sharp. 1991. The HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189–4196.
   PubMed Web of Science ®Google Scholar
• Marshall, N. F., and D. H. Price. 1992. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12:2078–2090.
   PubMed Web of Science ®Google Scholar
• Middleton, K. Μ., and G. T. Morgan. 1990. Premature termination of transcription can be induced on an injected α-tubulin gene in Xenopus oocytes. Mol. Cell. Biol. 10:727–735.
   PubMedGoogle Scholar
• Mott, J. E., J. L. Galloway, and T. Platt. 1985. Maturation of Escherichia coli tryptophan operon mRNA: evidence for 3' exonucleolytic processing after rho-dependent termination. EMBO J. 4:1887–1891.
   PubMed Web of Science ®Google Scholar
• Muesing, Μ. A., D. H. Smith, and D. J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691–701.
   PubMedGoogle Scholar
• Neuman de Vegvar, H. E., and J. E. Dahlberg. 1990. Nucleocy-toplasmic transport and processing of small nuclear RNA precursors. Mol. Cell. Biol. 10:3365–3375.
   PubMedGoogle Scholar
• Neuman de Vegvar, H. E., E. Lund, and J. E. Dahlberg. 1986. 3' end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell 47:259–266.
   PubMed Web of Science ®Google Scholar
• Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247:845–848.
   PubMedGoogle Scholar
• Pavlakis, G. N., and B. K. Felber. 1990. Regulation of expression of human immunodeficiency virus. New Biol. 2:20–31.
   PubMedGoogle Scholar
• Peterlin, B. Μ., P. A. Luciw, P. J. Barr, and Μ. D. Walker. 1986. Elevated levels of mRNA can account for the transactivation of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 83:9734–9738.
   PubMedGoogle Scholar
• Pfeifer, K., Μ. Bachmann, H. C. Schroder, B. E. Weiler, D. Ugarkovic, T. Okamoto, and W. E. Muller. 1991. Formation of a small ribonucleoprotein particle between Tat protein and trans-acting response element in human immunodeficiency virus-infected cells. J. Biol. Chem. 266:14620–14626.
   PubMedGoogle Scholar
• Ratnasabapathy, R., M. Sheldon, L. Johal, and N. Hernandez. 1990. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:2061–2074.
   PubMedGoogle Scholar
• Reines, D. 1992. Elongation factor-dependent transcript shortening by template-engaged RNA polymerase II. J. Biol. Chem. 267:3795–3800.
   PubMedGoogle Scholar
• Reines, D., D. Wells, Μ. J. Chamberlin, and C. Μ. Kane. 1987. Identification of intrinsic termination sites in vitro for RNA polymerase II within eukaryotic gene sequences. J. Mol. Biol. 196:299–312.
   PubMedGoogle Scholar
• Romaniuk, P. J., P. Lowary, H.-N. Wu, G. Stormo, and O. C. Uhlenbeck. 1987. RNA binding site of the R17 coat protein. Biochemistry 26:1563–1568.
   PubMedGoogle Scholar
• Rosen, C. A., J. G. Sodrowski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell Iymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813–823.
   PubMedGoogle Scholar
• Roy, S., U. Delling, C.-H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev. 4:1365–1373.
   PubMed Web of Science ®Google Scholar
• Roy, S., N. T. Parkin, C. Rosen, J. Itovitch, and N. Sonenberg. 1990. Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. J. Virol. 64:1402–1406.
   PubMedGoogle Scholar
• Sato, K., R. Ito, K.-H. Baek, and K. Agarwal. 1986. A specific DNA sequence controls termination of transcription in the gastrin gene. Mol. Cell. Biol. 6:1032–1043.
   PubMedGoogle Scholar
• Selby, Μ. J., E. S. Bain, P. A. Luciw, and B. Μ. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547–558.
   PubMed Web of Science ®Google Scholar
• Selby, Μ. J., and B. Μ. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769–776.
   PubMedGoogle Scholar
• Sheldon, Μ., and N. Hernandez. Unpublished results.
   Google Scholar
• Sheline, C. T., L. H. Milocco, and K. A. Jones. 1991. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:2508–2520.
   PubMedGoogle Scholar
• Southgate, C., and Μ. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5:2496–2507.
   PubMedGoogle Scholar
• Southgate, C., Μ. L. Zapp, and Μ. R. Green. 1990. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature (London) 345:640–642.
   PubMedGoogle Scholar
• Spencer, C. A., and Μ. Grondine. 1990. Transcription elongation and eukaryotic gene regulation. Oncogene 5:777–785.
   PubMed Web of Science ®Google Scholar
• Sullenger, B. A., H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601–608.
   PubMed Web of Science ®Google Scholar
• Tanaka, Μ., and W. Herr. 1990. Differentiation transcriptional activation by Oct-I and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375–386.
   PubMedGoogle Scholar
• Toohey, Μ. G., and K. A. Jones. 1989. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev. 3:265–282.
   PubMedGoogle Scholar
• Treisman, R., Μ. R. Green, and T. Maniatis. 1983. cis and trans activation of globin gene transcription in transient assays. Proc. Natl. Acad. Sci. USA 80:7428–7432.
   PubMed Web of Science ®Google Scholar
• Ucker, D. S., and K. R. Yamamoto. 1984. Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. Novel assays of transcription rates. J. Biol. Chem. 259:7416–7420.
   PubMed Web of Science ®Google Scholar
• Weeks, K. Μ., C. Ampe, S. C. Schultz, T. A. Steitz, and D. Μ. Crothers. 1990. Fragments of the HIV-1 TAT protein specifically bind TAR RNA. Science 249:1281–1285.
   PubMed Web of Science ®Google Scholar
• Weeks, K. Μ., and D. Μ. Crothers. 1991. RNA recognition by Tat-derived peptides: interaction in the major groove? Cell 66:577–588.
   PubMed Web of Science ®Google Scholar
• Wright, C. Μ., B. K. Felber, H. Paskalis, and G. N. Pavlakis. 1986. Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 234:988–992.
   PubMedGoogle Scholar
• Wu, F., J. Garcia, D. Sigman, and R. Gaynor. 1991. Tat regulates binding of the human immunodeficiency virus transactivating region RNA loop-binding protein TRP-185. Genes Dev. 5:2128–2140.
   PubMed Web of Science ®Google Scholar
• Yarnell, W. S., and J. W. Roberts. 1992. The phage λ gene Q transcription antiterminator binds DNA in the late gene promoter as it modifies RNA polymerase. Cell 69:1181–1189.
   PubMedGoogle Scholar
• Zoller, Μ., and Μ. Smith. 1982. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 10:6487–6500.
   PubMed Web of Science ®Google Scholar